|

Total neoadjuvant therapy (TNT) Clinical Trials

2 actively recruiting trials

Pipeline

Phase 2: 1

Top Sponsors

  • brenner baruch1
  • Helsinki University Central Hospital1

Indications

  • Cancer2
  • Locally Advanced Rectal Cancer (LARC)1
  • Colorectal Cancer1

Other2 trials

Systemic Neoadjuvant and Adjuvant Control by Precision Medicine in Rectal Cancer
N/A
Total Neoadjuvant Treatment With or Without Tislelizumab for Locally Advanced Rectal Cancer.
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.